🇺🇸 FDA
Patent

US 10179112

Viral vector nanocapsule for targeting gene therapy and its preparation

granted A61KA61K31/7088A61K47/62

Quick answer

US patent 10179112 (Viral vector nanocapsule for targeting gene therapy and its preparation) held by The Regents of the University of California expires Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/7088, A61K47/62, A61K47/6925, A61K9/513